Eton Pharmaceuticals Inc (ETON)
10.48
-0.12
(-1.13%)
USD |
NASDAQ |
Nov 14, 16:00
10.48
0.00 (0.00%)
After-Hours: 16:56
Eton Pharmaceuticals Revenue (TTM): 31.38M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 31.38M |
| March 31, 2024 | 34.30M |
| December 31, 2023 | 31.64M |
| September 30, 2023 | 32.83M |
| June 30, 2023 | 29.02M |
| March 31, 2023 | 24.38M |
| December 31, 2022 | 21.25M |
| September 30, 2022 | 18.85M |
| Date | Value |
|---|---|
| June 30, 2022 | 16.40M |
| March 31, 2022 | 12.11M |
| December 31, 2021 | 21.83M |
| September 30, 2021 | 15.82M |
| June 30, 2021 | 14.88M |
| March 31, 2021 | 11.84M |
| December 31, 2020 | 0.039M |
| September 30, 2020 | 0.417M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.039M
Minimum
Dec 2020
34.30M
Maximum
Mar 2024
19.81M
Average
20.05M
Median
Revenue (TTM) Benchmarks
| Biomarin Pharmaceutical Inc | 2.753B |
| Integra Lifesciences Holdings Corp | 1.565B |
| Elutia Inc | 24.99M |
| Immuneering Corp | -- |
| Journey Medical Corp | 77.68M |